Published: 18 January 2019
Author(s): Vincenzo Livio Malavasi, Marco Marietta, Gregory Y.H. Lip, Giuseppe Boriani
Section: Letter to the Editor
We appreciate the interest of Sorigue in our paper [1,2]. In his comments [2], he underlines several interesting points relevant to the management of atrial fibrillation (AF) in cancer patients.
